Health

The CDC concluded that by 2021, the "rate of drug overdose deaths involving xylazine was 35 times higher than the 2018 rate."

Penn Medicine is also weighing the possibility of re-establishing emergency care at Brandywine Hospital “beyond the partnership with the VA.”

Tower Health and Penn Medicine signed a letter of intent that would allow Penn to acquire Brandywine Hospital in Coatesville.

According to data the state shares with the federal government, nearly 20% of Pennsylvanians who had to renew their Medical Assistance coverage have lost it.

Pennsylvania law only allows physicians to perform abortions. Advanced practice clinicians say they want to be able to do the same.

The Commonwealth Fund’s 2023 state scorecard also graded New Jersey and Delaware as having a “better-than-average” health system performance.

Mobile crisis program supporters say additional funding will help to better staff professional teams and improve response times.

This injectable form of penicillin is a critical treatment for infections like syphilis, and could be in short supply for the rest of the year.

States were prohibited from removing people from Medicaid during the pandemic. But that ban was lifted in April.

From 10 a.m. to 2 p.m. on June 21 at the Wellness Center in Yeadon, healthcare professionals will administer the free test. Health officials say early detection is key.

Xylazine is being mixed into fentanyl across the U.S., but who's doing it and why is a mystery. The government still doesn't identify and track new drug threats.

Peripheral arterial disease is a serious health condition that causes blockage of blood vessels in the lower body that can lead to amputations.

Over the course of the next 18 years, Delco will receive $63 million in settlement payments. Now comes the tough part. What should Delco spend the money on?

Health disparities between Black and white Americans run deep in the U.S. Black people are more likely to suffer from chronic conditions ...

While infections have declined, the virus could be a real concern next winter, FDA's vaccine chief Dr. Peter Marks said as the daylong meeting began.